Thryv Therapeutics Inc.

Thryv Therapeutics is a clinical-stage biopharmaceutical company dedicated to advancing innovative therapies for patients with serious cardiovascular conditions, including Long QT Syndrome, heart failure, and atrial fibrillation.

Our mission is to help patients not just survive—but thryv.
Learn more about how we’re working to translate innovative science into meaningful impact for patients and families.